Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 2888-2898

  Hondalus, Mary K ^a,b   Bardarov, Stoyan ^a   Russell, Robert ^a   Chan, John ^a   Jacobs Jr , William R ^a   Bloom, Barry R ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE;

ALLELE; ARTICLE; AUXOTROPHY; BACTERIUM MUTANT; CONTROLLED STUDY; GENE DELETION; IMMUNOCOMPETENCE; INFECTION PREVENTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; HYDRO-LYASES; INTRACELLULAR FLUID; ISOMERASES; LEUCINE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, SCID; MUTAGENESIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0034114442     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.2888-2898.2000     Document Type: Article

References (66)

1. Ahmed, Z. U., M. R. Sarker, and D. A. Sack. 1990. Protection of adult rabbits and monkeys from a lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y. Vaccine 8:153-158.
2. Aldovoni, A., R. N. Husson, and R. A. Young. 1993. The uraA locus and homologous recombination in Mycobacterium bovis BCG. J. Bacteriol. 175: 7282-7289.
3. Aronson, J. D., C. F. Aronson, and H. C. Taylor. 1958. A twenty-year appraisal of BCG vaccination in the control of tuberculosis. Arch. Intern. Med. 101:881-893.
4. Azad, A. K., T. D. Sirakova, N. D. Fernandes, and P. E. Kolattukudy. 1997. Gene knockout reveals a novel gene cluster unique to pathogenic mycobacteria. J. Biol. Chem. 272:16741-16745.
5. Azad, K. A., T. D. Sirkova, L. M. Rogers, and P. E. Kolattukudy. 1996. Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides. Proc. Natl. Acad. Sci. USA 93:4787-4792.
6. Bacon, G. A., T. W. Burrows, and M. Yates. 1950. The effects of biochemical mutation on the virulence of Bacterium typhosum: the virulence of mutants. Br. J. Exp. Pathol. 31:714-723.
7. Balasubramanian, V., M. S. Pavelka, S. S. Bardarov, J. Martin, T. R. Weisbrod, R. A. Mcadam, B. R. Bloom, and W. R. Jacobs. Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. 1996. J. Bacteriol. 178:273-279.
8. Baldwin, S. L., C. D'Souza, A. D. Roberts, B. Kelly, A. A. Frank, M. A. Lui, J. B. Ulmer, K. Huygen, D. M. McMurray, and I. M. Orme. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
9. Bange, F.-C., A. M. Brown, and W. R. Jacobs. 1996 Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect. Immun. 64:1794-1799.
10. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523.
11. Bowe, F., P. O'Gaora, D. Maskell, M. Cafferkey, and G. Dougan. 1989. Virulence, persistence, and immunogenicity of Yersina enterocolitica O:8 aroA mutants. Infect. Immun. 57:3234-3236.
12. China Tuberculosis Control Collaboration. 1996. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 347:358-362.
13. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Conner, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, L. K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
14. Cooper, G. L., L. M. Venables, M. J. Woodward, and C. E. Hormaeche. 1994. Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate. 62:4747-4754.
15. Desai, S. A., D. J. Krogstad, and E. W. McCleskey. 1993. A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature 362:643-646.
16. Dougan, G., D. Maskell, D. Pickard, and C. Hormaeche. 1987. Isolation of stable aroA mutants of Salmonella typhi Ty2: properties and preliminary characterization in mice. Mol. Gen. Genet. 207:402-405.
17. Dubos, R. J., and W. B. Schaefer. 1956. Antituberculous immunity induced in mice by virulent primary infection. Am. Rev. Tuberculous Pulm. Dis. 74:541-551.
18. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement, global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance Monitoring Project. JAMA 282:677-686.
19. Fields, P. I., R. V. Swanson, C. G. Haidaris, and F. Heffron. 1986. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. USA 83:5189-5193.
20. Gay, P., D. LeCoq, M. Steinmetz, T. Berkelman, and C. I. Kado. 1985. Positive selection procedure for entrapment of insertion sequence elements in gram-negative bacteria. J. Bacteriol. 164:918-921.
21. Guliera, I., R. Tietelbaum, R. A. McAdam, G. Kalpana, W. R. Jacobs, Jr., and Barry R. Bloom. 1996. Auxotrophic vaccines for tuberculosis. Nat. Med. 2:334-337.
22. Harrington, R., and A. G. Karlson. 1966. Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by in vitro procedures. Am. J. Vet. Res. 27:1193-1196.
23. Hart, P. D., and I. Sutherland. 1977. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early life. Br. Med. J. 22:293-295.
24. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
25. Homchampa, P., R. A. Strugnell, and B. Adler. 1992. Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of constructed aroA mutants. Mol. Miciobiol. 8:3585-3593.
26. Hubbard, R. D., C. M. Flory, C. Cocito, and F. M. Collins. 1992. Immunization of mice with antigen A60 of Mycobacterium bovis BCG. Clin. Exp. Immunol. 88:129-131.
27. Husson, R. N., B. E. James, and R. A. Young. 1990. Gene replacement and expression of foreign DNA in mycobacteria. J. Bacteriol. 172:519-524.
28. -) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect. Immun. 58:303-308.
29. Jackson, M., S. W. Phalen, M. Langranderie, D. Ensergueix, P. Chavarot, G. Marchai, D. N. McMurray, B. Gicquel, and C. Guilhot. 1999. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotrophic vaccine. Infect. Immun. 67:2867-2873.
30. Kalpana, G. V., B. R. Bloom, and W. R. Jacobs. 1991. Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc. Natl. Acad. Sci. USA 88:5433-5437.
31. Kanai, K., and K. Yanagisawa. 1955. Studies on the reinfection in experimental tuberculosis of guinea pigs. Jpn. J. Med. Sci. Biol. 8:115-127.
32. Karnell, A., B. A. Stocker, S. Katakura, H. Sweiha, F. P. Reinholt, P. D. Cam, D. D. Reach, and A. A. Lindberg. 1991. An auxotrophic live oral Shigella flexneri vaccine: development and testing. Rev. Infect. Dis. 13(Suppl. 4): S357-S361.
33. Leung, K. Y., and B. B. Findlay. 1991. Intracellular replication is essential for the virulence of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 88: 11470-11474.
34. Marhairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
35. Marquis, H., H. G. A. Bouwer, D. J. Hinrichs, and D. A. Portnoy. 1993. Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect. Immun. 61:3756-3760.
36. McAdam, R. A., T. R. Weisbrod, J. Martin, J. D. Scuderi, A. M. Brown, J. D. Cirillo, B. R. Bloom, and W. R. Jacobs, Jr. 1995. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect. Immun. 63:1004-1012.
37. McFadden, J. 1996. Recombination in mycobacteria. Mol. Microbiol. 21: 205-211.
38. McFarland, W. C., and B. A. D. Stocker. 1987. Effect of different purine auxotrophic mutations on mouse virulence of a Vi-positive strain of Salmonella dublin and two strains of Salmonella typhimurium. Microb. Pathog. 3:129-141.
39. McKenney, D., K. L. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Doring, J. C. Lee, D. Goldmann, and G. B. Pier. 1999. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284: 1523-1527.
40. Mintz, C. S., J. Chen, and H. A. Shuman. 1988. Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes. Infect. Immun. 56:1449-1455.
41. Murray, C. J. L., and A. D. Lopez. 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442.
42. Murray, C. J. L., and J. A. Solomon. 1998. Modeling the impact of global tuberculosis control strategies. Proc. Natl. Acad. Sci. USA 95:13881-13886.
43. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. F. Easmon, and G. Dougan. 1988. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423.
44. Okada, N., C. Saskawa, T. Tobe, M. Yamada, S. Nagai, K. A. Talukder, K. Komatsu, S. Kanegasuki, and M. Yoshikawa. 1991. Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol. Microbiol. 5:187-195.
45. Opie, E. L., and J. Freund. 1937. An experimental study of protective inoculation with heat killed tubercle bacilli. J. Exp. Med. 66:761-788.
46. Pavelka, M. S., Jr., and W. R. Jacobs. 1996. Biosynthesis of diaminopimelate (DAP), the precursor of lysine and a component of the peptidoglycan, is an essential function of Mycobacterium tuberculosis. J. Bacteriol. 178:6496-6507.
47. Pavelka, M. S., Jr., and W. R. Jacobs. 1999. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis Bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J. Bacteriol. 181:4780-4789.
48. Pelicic, V., M. Jackson, J. M. Reyrat, W. R. Jacobs, Jr., B. Gicquel, and C. Guilhot. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10955-10960.
49. Reyrat, J.-M., F.-X. Berthet, and B. Gicquel. 1995. The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis Bacillus Calmette Guerin. Proc. Natl. Acad. Sci. USA 92:8768-8772.
50. Rimphanitchayakit, V., G. F. Hatfull, and N. D. Grindley. 1989. The 43 residue DNA binding domain of gamma delta resolvase binds adjacent major and minor grooves of DNA. Nucleic Acids Res. 17:1035-1050.
51. Roberts, M., D. Maskell, P. Novotny, and G. Dougan. 1990. Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect. Immun. 58:732-739.
52. Rodrigues, L. C., N. Gill, and P. G. Smith. 1991. BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England. J. Epidemiol. Community Health 45:78-80.
53. Sander, P., A. Meier, and E. C. Bottger. 1995. Rps1+: a dominant selectable marker for gene replacement in mycobacteria. Mol. Microbiol. 16:991-1000.
54. Schwab, J. C., C. Beckers, and K. A. Joiner. 1992. A putative pore in the parasitophorous vacuole membrane of Toxoplasma gondii identified by microinjection of fluorescent probes. Mol. Biol. Cell. 3(Suppl.):303a.
55. Segall, T., and A. A. Linberg. 1991. Salmonella dublin experimental infection in calves: protection after oral immunization with an auxotrophic aroA live vaccine. J. Vet. Med. Ser. B. 38:142-160.
56. Simmons, P., A. L. M. Hodgson, and R. A. Strugnell. 1997. Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis. Infect. Immun. 65:3048-3056.
57. Smith, B. P., M. Reina-Guerra, B. A. Stocker, and E. Johnson. 1984. Aromatic-dependent Salmonella dublin as a parental modified live vaccine for calves. Am. J. Vet. Res. 45:2231-2235.
58. Smith, T. 1917. Certain aspects of natural and acquired resistance to tuberculosis and their bearing on preventative measures. JAMA 68:764-679.
59. Stover, K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. Young, M. Lee, G. F. Hatfull, S. Snapper, R. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
60. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddis, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russel. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681.
61. Tascon, R. E., M. J. Colston, S. Ragro, E. Stavropoulous, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. 8:888-892.
62. Tsenova, L., A. Moreira, E. Party, V. H. Freedmanj, and G. Kaplan. 1997. Aerosol infection of mice with mycobacteria using a nose-only exposure device. J. Am. Biol. Saf. Assoc. 2:20-31.
63. Tuberculosis Prevention Trial. Madras. 1980. Trial of BCG vaccines in South India for tuberculosis prevention. Indian J. Med. Res. 72:1-74.
64. World Health Organization. 1999. The world health report 1999. Making a difference. World Health Organization, Geneva, Switzerland.
65. Yaun, Y., D. D. Crane, R. M. Simpson, Y. Q. Zhu, M. J. Hickey, D. R. Sherman, and C. E. Barry III. 1998. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. 95:9578-9583.
66. Zinsser, H., H. K. Ward, and F. B. Jennings. 1925. The significance of bacterial allergy as a sign of resistance. J. Immunol. 10:719-723.